AT13387 is a specific inhibitor of Hsp90 that can inhibit the expression of AKT/p-AKT, EGFR and p-STAT3 in EBV-positive nasopharyngeal carcinoma cells, thereby restoring p27 to inhibit cancer cell proliferation [92]. The gene discussed is AKT1; the disease is nasopharyngeal carcinoma.